Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Microbial Biosensors

Microbial Biosensors

Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Performance of the HFpEF-ABA, H<sub>2</sub>FPEF, and HFA-PEFF Algorithms in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.

Journal of cardiac failure·2026

Same author

Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials.

European journal of heart failure·2026

Same author

Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.

Journal of the American College of Cardiology·2025

Same author

Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.

Journal of the American College of Cardiology·2025

Same author

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.

European heart journal. Cardiovascular pharmacotherapy·2025

Same author

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials.

JACC. Heart failure·2025

Search research articles

Related Experiment Video

Updated: May 24, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Biomarkers.

Viorel G Florea¹, Inder S Anand

¹Department of Medicine, University of Minnesota Medical School, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA. flore022@umn.edu

Heart Failure Clinics

|March 13, 2012

Summary

Research identifies conditions leading to heart failure and asymptomatic left ventricular dysfunction. While natriuretic peptides and troponin are used for advanced heart failure, other biomarkers offer insights for future therapies.

Area of Science:

Cardiology
Biochemistry
Epidemiology

Background:

Heart failure is preceded by asymptomatic left ventricular remodeling and dysfunction (stage B heart failure).
Various biochemical markers are associated with cardiac remodeling and dysfunction.
Current biomarkers like natriuretic peptides and cardiac troponin aid in managing advanced heart failure (stages C and D).

Purpose of the Study:

To review antecedent conditions predisposing individuals to heart failure.
To discuss biochemical markers characterizing left ventricular remodeling and dysfunction.
To explore the potential of novel biomarkers in understanding pathophysiology and developing new therapies.

Main Methods:

Review of epidemiologic, clinical, and basic research.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Analysis of described biochemical markers.

Discussion of current biomarker applications and future research directions.

Main Results:

Several conditions predispose individuals to stage B heart failure.
Numerous biochemical markers are linked to cardiac remodeling and dysfunction.
Beyond natriuretic peptides and troponin, other biomarkers offer insights into left ventricular dysfunction.

Conclusions:

Understanding early stages of heart failure is crucial.
Biomarkers beyond current clinical use hold potential for research and therapeutic development.
Further investigation into novel biomarkers may reveal new treatment strategies for heart failure.